A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma.
Crit Rev Oncol Hematol
; 172: 103639, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35192932
Full text:
1
Database:
MEDLINE
Main subject:
Mesothelioma, Malignant
/
Lung Neoplasms
Type of study:
Prognostic_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Crit Rev Oncol Hematol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
France